- 12366-52-8LACTIC ACID, SODIUM ZIRCONIUM SALT (4:4:1)
- 1236699-92-5N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodo-anilino)pyridine-4-carboxamide
- 123677-05-42-Naphthalenecarboxamide,N-(2-chlorophenyl)-3-hydroxy-4-[2-[2-methyl-4-[2-(9-oxo-9H-fluoren-2-yl)diazenyl]phenyl]diazenyl]-
- 123-68-2Allyl hexanoate
- 123689-95-2Butanenitrile,3-hydroxy-, (3S)-
- 123690-76-6Octacosanoic acid,2-(4-hydroxyphenyl)ethyl ester
- 123690-78-8Phosphinic acid,(3-aminopropyl)butyl-
- 123691-14-5Phosphinic acid,P-(3-aminopropyl)-P-(cyclohexylmethyl)-
- 123-69-3Oxacycloheptadec-8-en-2-one,(8Z)-
- 123695-38-53-Chloroisoquinoline-4-carboxylic acid
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Iguratimod |
EINECS | 808-127-0 |
| CAS No. | 123663-49-0 | Density | 1.52 g/cm3 |
| PSA | 123.09000 | LogP | 4.38780 |
| Solubility | N/A | Melting Point |
238.0 to 242.0 °C |
| Formula | C17H14N2O6S | Boiling Point | 580.6 °C at 760 mmHg |
| Molecular Weight | 374.374 | Flash Point | 304.9 °C |
| Transport Information | N/A | Appearance | white powder |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
T 614;T614 (antiinflammatory);Ailamode;3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one;N-[3-(Formylamino)-4-oxo-6-phenoxy-4H-chromen-7-yl]methanesulfonamide; |
Article Data | 5 |
Iguratimod Synthetic route
- 4637-24-5
N,N-dimethyl-formamide dimethyl acetal
- 149457-03-4
α-formamido-2'-hydroxy-4'-methanesulfonamido-5'-phenoxyacetophenone
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| In N,N-dimethyl-formamide at 15℃; for 8h; Cyclization; | 87% |
- 2258-42-6
Acetic formic anhydride
- 123663-48-9
N-(3-amino-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl)methanesulfonamide
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| In dichloromethane at 20℃; for 1h; Formylation; | 73% |
- 123663-48-9
N-(3-amino-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl)methanesulfonamide
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| With formic acid; acetic anhydride In dichloromethane; di-isopropyl ether | 73% |
- 84594-95-6
4-methoxy-2-nitro-1-phenoxybenzene
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| Multi-step reaction with 6 steps 1: 72 percent / 4N aq. HCl; Fe / ethanol / 0.33 h / 65 - 70 °C 2: 82 percent / pyridine / 1 h / 20 °C 3: 90 percent / AlCl3; HCl / nitrobenzene / 10 h / 25 - 30 °C 4: 91 percent / acetone / 3 h 5: 95 percent / NaI; AlCl3 / acetonitrile / 3 h / 20 °C 6: 87 percent / dimethylformamide / 8 h / 15 °C View Scheme | |
| Multi-step reaction with 9 steps 1: 72 percent / 4N aq. HCl; Fe / ethanol / 0.33 h / 65 - 70 °C 2: 82 percent / pyridine / 1 h / 20 °C 3: 84 percent / aluminum chloride / CH2Cl2 / 1 h / 15 - 20 °C 4: 70 percent aq. HClO4 / 1 h / 20 °C 5: H2O / 0.08 h / Heating 6: H2 / 5 percent Pd/C / acetic acid / 1 h / 40 - 45 °C / 760 Torr 7: 97 percent / Br2 / CHCl3 / 0.5 h / 25 - 30 °C 8: 80 percent / NaN3; DMF / 1 h / 70 - 75 °C 9: 73 percent / CH2Cl2 / 1 h / 20 °C View Scheme |
- 76838-72-7
5-methoxy-2-phenoxyaniline
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| Multi-step reaction with 5 steps 1: 82 percent / pyridine / 1 h / 20 °C 2: 90 percent / AlCl3; HCl / nitrobenzene / 10 h / 25 - 30 °C 3: 91 percent / acetone / 3 h 4: 95 percent / NaI; AlCl3 / acetonitrile / 3 h / 20 °C 5: 87 percent / dimethylformamide / 8 h / 15 °C View Scheme | |
| Multi-step reaction with 8 steps 1: 82 percent / pyridine / 1 h / 20 °C 2: 84 percent / aluminum chloride / CH2Cl2 / 1 h / 15 - 20 °C 3: 70 percent aq. HClO4 / 1 h / 20 °C 4: H2O / 0.08 h / Heating 5: H2 / 5 percent Pd/C / acetic acid / 1 h / 40 - 45 °C / 760 Torr 6: 97 percent / Br2 / CHCl3 / 0.5 h / 25 - 30 °C 7: 80 percent / NaN3; DMF / 1 h / 70 - 75 °C 8: 73 percent / CH2Cl2 / 1 h / 20 °C View Scheme |
- 10298-80-3
2-chloro-5-methoxynitrobenzene
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| Multi-step reaction with 7 steps 1: 84 percent / potassium tert-butoxide / dimethylformamide / 4 h / 110 °C 2: 72 percent / 4N aq. HCl; Fe / ethanol / 0.33 h / 65 - 70 °C 3: 82 percent / pyridine / 1 h / 20 °C 4: 90 percent / AlCl3; HCl / nitrobenzene / 10 h / 25 - 30 °C 5: 91 percent / acetone / 3 h 6: 95 percent / NaI; AlCl3 / acetonitrile / 3 h / 20 °C 7: 87 percent / dimethylformamide / 8 h / 15 °C View Scheme | |
| Multi-step reaction with 10 steps 1: 84 percent / potassium tert-butoxide / dimethylformamide / 4 h / 110 °C 2: 72 percent / 4N aq. HCl; Fe / ethanol / 0.33 h / 65 - 70 °C 3: 82 percent / pyridine / 1 h / 20 °C 4: 84 percent / aluminum chloride / CH2Cl2 / 1 h / 15 - 20 °C 5: 70 percent aq. HClO4 / 1 h / 20 °C 6: H2O / 0.08 h / Heating 7: H2 / 5 percent Pd/C / acetic acid / 1 h / 40 - 45 °C / 760 Torr 8: 97 percent / Br2 / CHCl3 / 0.5 h / 25 - 30 °C 9: 80 percent / NaN3; DMF / 1 h / 70 - 75 °C 10: 73 percent / CH2Cl2 / 1 h / 20 °C View Scheme |
- 123664-84-6
N-(5-methoxy-2-phenoxyphenyl)methanesulfonamide
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| Multi-step reaction with 4 steps 1: 90 percent / AlCl3; HCl / nitrobenzene / 10 h / 25 - 30 °C 2: 91 percent / acetone / 3 h 3: 95 percent / NaI; AlCl3 / acetonitrile / 3 h / 20 °C 4: 87 percent / dimethylformamide / 8 h / 15 °C View Scheme | |
| Multi-step reaction with 7 steps 1: 84 percent / aluminum chloride / CH2Cl2 / 1 h / 15 - 20 °C 2: 70 percent aq. HClO4 / 1 h / 20 °C 3: H2O / 0.08 h / Heating 4: H2 / 5 percent Pd/C / acetic acid / 1 h / 40 - 45 °C / 760 Torr 5: 97 percent / Br2 / CHCl3 / 0.5 h / 25 - 30 °C 6: 80 percent / NaN3; DMF / 1 h / 70 - 75 °C 7: 73 percent / CH2Cl2 / 1 h / 20 °C View Scheme |
- 123664-52-8
methyl 2-hydroxy-4-methylsulfonylamino-5-phenoxyphenyl ketone
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| Multi-step reaction with 6 steps 1: 70 percent aq. HClO4 / 1 h / 20 °C 2: H2O / 0.08 h / Heating 3: H2 / 5 percent Pd/C / acetic acid / 1 h / 40 - 45 °C / 760 Torr 4: 97 percent / Br2 / CHCl3 / 0.5 h / 25 - 30 °C 5: 80 percent / NaN3; DMF / 1 h / 70 - 75 °C 6: 73 percent / CH2Cl2 / 1 h / 20 °C View Scheme |
- 123662-55-5
7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| Multi-step reaction with 4 steps 1: H2 / 5 percent Pd/C / acetic acid / 1 h / 40 - 45 °C / 760 Torr 2: 97 percent / Br2 / CHCl3 / 0.5 h / 25 - 30 °C 3: 80 percent / NaN3; DMF / 1 h / 70 - 75 °C 4: 73 percent / CH2Cl2 / 1 h / 20 °C View Scheme |
- 123664-21-1
N-(4-oxo-6-phenoxy-2,3-dihydro-4H-7-chromenyl)methanesulfonamide
- 123663-49-0
Iguratimod
| Conditions | Yield |
|---|---|
| Multi-step reaction with 3 steps 1: 97 percent / Br2 / CHCl3 / 0.5 h / 25 - 30 °C 2: 80 percent / NaN3; DMF / 1 h / 70 - 75 °C 3: 73 percent / CH2Cl2 / 1 h / 20 °C View Scheme |
Iguratimod Chemical Properties
Molecular Structure of Methanesulfonamide,N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]- (CAS NO.123663-49-0):
Molecular Formula: C17H14N2O6S
Molecular Weight: 374.3679
IUPAC Name: N-[7-(Methanesulfonamido)-4-oxo-6-phenoxychromen-3-yl]formamide
Synonyms of Methanesulfonamide,N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]- (CAS NO.123663-49-0): Iguratimod [INN] ; 3-Formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one ; Iguratimod ; N-(7-((Methylsulfonyl)amino)-4-oxo-6-phenoxy-4H-1-benzopyran-3-yl)formamide ; T 614 ; T-614 ; UNII-4IHY34Y2NV
CAS NO: 123663-49-0
Classification Code: API ; Pharmaceutical intermediate ; Pharmaceuticals
Index of Refraction: 1.673
Molar Refractivity: 92.3 cm3
Molar Volume: 246 cm3
Surface Tension: 72.3 dyne/cm
Density: 1.52 g/cm3
Flash Point: 304.9 °C
Enthalpy of Vaporization: 86.84 kJ/mol
Boiling Point: 580.6 °C at 760 mmHg
Vapour Pressure of Methanesulfonamide,N-[3-(formylamino)-4-oxo-6-phenoxy-4H-1-benzopyran-7-yl]- (CAS NO.123663-49-0): 1.8E-13 mmHg at 25°C
What can I do for you?
Get Best Price
